DarioHealth Corp (DRIO) Stock Analysis
Verdict: WATCH (do not buy)
Steep revenue contraction and -184% operating margins outweigh insider optimism, signaling a high-risk turnaround play facing dilution.
Investment score: 42/100
Analysis as of
Is DarioHealth Corp stock worth reviewing? The TradeMates thesis
DARIOHEALTH CORP is a high-risk digital health micro-cap currently struggling with declining revenues and extreme operating losses. Although gross margins are healthy at 56%, the company's cash runway is approximately 12 months based on current FCF burn. Until revenue growth return and burn narrows, the model views the 96% analyst upside as unrealistically optimistic.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 20/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 75/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 30/100 (weight 15%)
DarioHealth Corp opportunities and risks
What speaks for DRIO
- Integrated B2B Pivot
What speaks against DRIO
- Liquidity Trap
Peers and competitors
- HCAT
- CCLD
- FORA
- CBRF
- AIFF
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| DRIO | 6.5x | 2.7x | n/a | 56.6% | 276.1% | -44.0% |
| HCAT | n/a | 0.4x | 16.5x | 33.5% | -57.2% | -4.1% |
| CCLD | 10.7x | 0.8x | 3.9x | 23.3% | 7.9% | 26.0% |
| FORA | n/a | 2.2x | n/a | 52.5% | -9.5% | 4.3% |
| CBRF | n/a | 123.3x | n/a | -16.2% | -459.3% | -2.9% |
| AIFF | n/a | 24.6x | n/a | 56.5% | -1741.0% | -29.6% |
| Peer median | n/a | 2.2x | n/a | 33.5% | -57.2% | -2.9% |
Frequently asked questions about DarioHealth Corp (DRIO)
Is DRIO stock a good investment?
The TradeMates model rates DarioHealth Corp as WATCH (do not buy) with an investment score of 42/100. DARIOHEALTH CORP is a high-risk digital health micro-cap currently struggling with declining revenues and extreme operating losses. Although gross margins are healthy at 56%, the company's cash runway is approximately 12 months based on current FCF burn. Until revenue growth return and burn narrows, the model views the 96% analyst upside as unrealistically optimistic. This is algorithmic model output, not personal investment advice.
Is DRIO stock a buy?
The TradeMates model verdict for DRIO is WATCH (do not buy) with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.